Tigermed Officially Opens International Headquarters in Hong Kong
HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.
- HONG KONG, Aug. 16, 2023 /PRNewswire/ -- Tigermed (300347.SZ/3347.HK), a leading global Contract Research Organization (CRO) providing integrated research and development solutions for the biopharmaceutical and medical device industry, officially announced the opening of its International Headquarters in Hong Kong, marking an important and exciting step forward on the path of global operation and corporate development.
- The International Headquarters will enable Tigermed to coordinate and manage global projects more efficiently, drive business expansion, and empower customers on a global scale.
- In August 2020, Tigermed was listed on the Hong Kong Stock Exchange (HKSE), marking the landing of the company's "A + H" dual-capital platform.
- The opening of Tigermed International Headquarters in Hong Kong demonstrated its strong commitment to expanding research capability and global reach to build a full-spectrum service platform.